Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Here we generated a pan-cancer spatial atlas of 400 tumours across 13 tissue types and 26 subtypes from the Asia-Pacific, a region under-represented in existing pan-cancer datasets. In a multimodal cohort we integrated single-cell spatial transcriptomics (1,999 genes) with more than 70 proteins measured in the same cells as built-in validation, alongside clinical data including ancestry, age, sex and survival. ASTRA1.0 revealed that each cancer subtype has distinct expression profiles and cellular compositions. Despite this heterogeneity, we identified eight recurrent spatial cellular neighbourhoods shared across tissue types, with macrophages as key organisers. We further developed a framework to quantify the co-localisation of FDA-approved drug targets with surrounding cell types. This framework classified tumours into four Spatial Theratope subtypes, each defined by a distinct signature of co-localised targets. The VEGF-A–PD-L1 pair, targeted by bevacizumab and atezolizumab, recurred across tumour types and neighbourhoods. Spatial Theratope subtypes and neighbourhood composition were each associated with progression-free survival (PFS) in the discovery cohort, and their combination was also associated with PFS in an independent cohort of 25 patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab. The ASTRA atlas provides a community resource for nominating rational, spatially informed combination therapies across cancers.
Source: Research Square
Authors: Ankur Sharma, Lucy Chhuo, Yoshiki Otsuka, Hitomi Kawai, Merrin Eapen, Ryutaro Sekimoto, Kei Asayama, Ryota Matsuoka, Abhishek Singh, Toshiro Niki, Noriyoshi Fukushima, Kentaro Inamura, Skye van Esch, Elgene Lim, Egor Revkov, Dana Idais, Shiro Oka, Atsushi Ono, Makoto Yamagishi, Thang Le, Wei-Chou Lin, Lin-Hung Huang, Yi-Chia Chiu, Atsushi Kaneda, toyoyuki Hanazawa, Takuya Nakagawa, Annabel Faulkner, Jordan Conway, Georgina Long, Ines Pires de Silva, Helen McGuire, Hidewaki Nakagawa, Ruby Huang, Takayuki Ueno, Junki Koike, Rie Horii, Satoi Nagasawa, Masaki Shiota, Sotaro Chikamatsu, Shota Sasagawa, Yutaka Hatanaka, Masakazu Fujii, Masaya Onishi, Masahito Shimizu, Liang Qiao, Ayako Suzuki, Daisuke Matsubara, Jacob George, Yutaka Suzuki, Yukinori Ozaki
Institutions: Garvan Institute of Medical Research, The University of Tokyo, University of Tsukuba, Jichi Medical University, UNSW Sydney, The Kinghorn Cancer Centre, Hiroshima University, National Taiwan University, Chiba University, The University of Sydney, Royal North Shore Hospital, Melanoma Institute Australia, RIKEN Center for Integrative Medical Sciences, Japanese Foundation For Cancer Research, Kyushu University, Hokkaido University, Hokkaido University Hospital, Gifu University, Westmead Hospital
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7225887112
